• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Eli Lil­ly inks an­oth­er obe­si­ty pact, dou­bling down on small Swiss part­ner

7 months ago
Startups
Deals

Im­mat­ics heads to Phase 3 with melanoma cell ther­a­py, seeks to raise $150M

7 months ago
Financing
R&D

Sen. War­ren urges FTC to ‘care­ful­ly scru­ti­nize’ No­vo-Catal­ent deal over com­pe­ti­tion con­cerns

7 months ago
Deals
Pharma

Bax­ter plots re­cov­ery af­ter Hur­ri­cane He­lene, Mil­li­pore­Sig­ma’s €290M fa­cil­i­ty

7 months ago
Manufacturing

Ex­clu­sive: How an ac­ci­den­tal email tipped Pfiz­er off to an ac­tivist in­vestor’s plan

7 months ago
People
Pharma

AI biotechs Re­cur­sion and Ex­sci­en­tia first held deal talks in 2022

7 months ago
Deals
AI

Ono’s ADC deal; Leo Phar­ma to con­duct lay­offs

7 months ago
News Briefing

Star­board launch­es first sal­vo in Pfiz­er fight, al­leg­ing ex-CEO, CFO were pres­sured to flip

7 months ago
R&D

Su­ki nabs $70M Se­ries D to arm doc­tors with AI tools

7 months ago
Startups
AI

Ex­clu­sive: Reema Health rais­es $7.6M to reach peo­ple on Med­ic­aid

7 months ago
Financing
Health Tech

Clients add pres­sure to CD­MOs to source raw ma­te­ri­als out­side of Chi­na, ex­ecs say

7 months ago
China
Manufacturing

Grit­stone files for bank­rupt­cy, says it could forge a trans­ac­tion as ear­ly as this month to keep R&D go­ing

7 months ago
Financing
R&D

For­mer Pfiz­er CEO and CFO flip on ac­tivist and say they now sup­port com­pa­ny

7 months ago
People
Pharma

Spa­tial bi­ol­o­gy com­pa­nies Viz­gen and Ul­tivue merge amid on­go­ing law­suits

7 months ago
Deals
Pharma

CMS looks to $2 out-of-pock­et cap for some com­mon­ly used gener­ic drugs

7 months ago
Pharma
FDA+

Ex­clu­sive Q&A: FDA's prin­ci­pal deputy com­mis­sion­er on tak­ing over for Califf, ad­comms, ac­cel­er­at­ed ap­provals and more

7 months ago
People
FDA+

GSK to pay up to $2.2B to set­tle al­most all Zan­tac-re­lat­ed court cas­es

7 months ago
Pharma

Cov­er­ing obe­si­ty drugs could cost Medicare $35B by 2034, CBO says

7 months ago
FDA+

Ma­jor PBMs call for re­mov­ing three FTC com­mis­sion­ers from in­sulin law­suit

7 months ago
Pharma
Law

Il­lu­mi­na's pitch for new ma­chines: You, too, can se­quence DNA

7 months ago
Diagnostics

‘Just the be­gin­ning’: No­bel Prizes show the AI era has ar­rived in biotech

7 months ago
R&D
AI

Cri­net­ics’ $500M of­fer­ing; Boehringer inks deal with macro­cy­cles biotech

7 months ago
News Briefing

Zealand Phar­ma hit with sec­ond CRL for glucagon re­cep­tor ag­o­nist

7 months ago
Pharma
FDA+

Clear­side shares jump as re­for­mu­lat­ed TKI drug pass­es mid-stage test in wet AMD

7 months ago
R&D
First page Previous page 83848586878889 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times